|
|
 |
|
Viewing report
|
|
|
|
India Pharmaceutical Regulatory Report 2011
Pacific Bridge Medical, April 2011
The India Pharmaceutical Regulatory Report comprehensively covers all aspects of pharmaceutical regulations in India. It includes overviews of the laws and procedures on registration, manufacturing, distribution, price control, marketing, research and development, and intellectual property protection. It also includes an overview of the Indian pharmaceutical market and foreign involvement in the market up to 2011. As India's pharmaceutical market is poised for steady growth, reaching an estimated $13 billion, understanding of Indian regulatory issues is crucial for success.
Updates for 2011 include:.
- Latest healthcare developments in India and their impact on foreign drug companies.
- India's new regulations on clinical establishments, clinical trials and GLPs affecting foreign drug companies.
- Updated government guidelines regarding new drug manufacturing and sales in India.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Also available
India Pharmaceutical Regulatory Report 2011 + Appendix
|
|
|
|
